Figure 2
Survival of CN-AML patients according to age group and LEF1 expression. (A) RFS and (B) OS of CN-AML patients younger than 60 years of age. (C) RFS and (D) OS of CN-AML patients aged 60 years or older.
Survival of CN-AML patients according to age group and LEF1 expression. (A) RFS and (B) OS of CN-AML patients younger than 60 years of age. (C) RFS and (D) OS of CN-AML patients aged 60 years or older.
